March 17, 2020 / 8:32 AM / 23 days ago

BRIEF-Dechra Acquires Worldwide Rights To Mirataz

March 17 (Reuters) - Dechra Pharmaceuticals PLC:

* DECHRA ACQUIRES WORLDWIDE RIGHTS TO MIRATAZ (R)

* TO BUY RIGHTS TO MIRATAZ FROM KINDRED BIOSCIENCES FOR USD43.0 MILLION AND A ROYALTY ON FUTURE SALES

* ACQUISITION WILL BE FINANCED FROM GROUP’S EXISTING CASH AND BORROWING FACILITIES

* DESPITE EQUITY MARKET CONDITIONS, CHANGING DEVELOPMENTS ON VIRUS, BUSINESS REMAINS ROBUST, STRONG BALANCE SHEET & CASH FLOW Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below